Gene interactions and pathways from curated databases and text-mining

◀ Back to ANGPT2

ANGPT2 — POLDIP2

Text-mined interactions from Literome

Deguchi et al., Circ Res 1999 : In newborn rat VSMCs, Ang II activates extracellular signal regulated protein kinase ( ERK ), c-Jun N-terminal protein kinase (JNK), and p38 mitogen activated protein kinase
Tsiani et al., Am J Physiol Endocrinol Metab 2002 : In HG, activation of p38 by ET-1, ANG II , or PDGF was enhanced compared with NG and was protein kinase C ( PKC ) independent
El Bekay et al., Blood 2003 (Calcium Signaling...) : Furthermore, Ang II induced a robust phosphorylation of p38MAPK , ERK1/2, and JNK1/2 ( particularly JNK2 ), which was hindered by inhibitors of NADPH oxidase, tyrosine kinases, and ROS scavengers
Li et al., Circulation 2004 (MAP Kinase Signaling System) : In WT aortae, Ang II increased NADPH dependent O2- production ( 2.5+/-0.5-fold ; P < 0.05 ), impaired relaxation to acetylcholine ( maximum 60+/-6 % versus 80+/-3 % ; P < 0.05 ), and increased ERK1/2, p38MAPK , and JNK phosphorylation ( P < 0.05 )
Li et al., Free Radic Biol Med 2005 (Cardiomegaly) : Ang II induced the phosphorylation of PKC, Erk1/2, JNK, and p38 in cardiomyocytes and such phosphorylation was inhibited by ISO
Su et al., Kidney Int 2006 : Ang II ( 5 min, 10 ( -7 ) M ) stimulated phosphorylation of the three MAPK ( p38 , extracellular signal related kinase ( ERK 1/2 ), and c-Jun N-terminal kinase (JNK) )
Liu et al., Circ Res 2006 (Body Weight...) : In addition, Ang II-induced AT(1)R expression was blocked by losartan and a JNK inhibitor, but not by extracellular signal regulated kinase or p38 MAP kinase inhibitors in a neuronal cell culture
Pham et al., J Cell Physiol 2008 : Ang II and EGF induced transient phosphorylation of ERK, p38 ( MAPK ) and CREB
Nie et al., Mol Immunol 2009 : Both Ang- ( 1-7 ) and Ang II had no effect on p38 and c-Jun N-terminal kinase (JNK) phosphorylation
Lin et al., PloS one 2012 (Cardiomegaly) : Angeli 's salt also suppresses Ang II induction of key triggers of the cardiomyocyte hypertrophic response, including NADPH oxidase ( on both Nox2 expression and superoxide generation ), as well as p38 mitogen activated protein kinase ( p38MAPK )